Growing Your Biopharma: Ten Questions You're Likely To Face From Investors And How To Respond To Them

There are many important considerations to address in building your new drug program. Without a doubt, one of the most critical is funding to get you to your next milestone. As you grapple with funding issues, it can be useful to consider the point of view of a potential investor.

Why? Because investors are betting on you to manage development effectively and to move quickly. In assembling this guide, we asked investment veterans and biopharma executives what questions they ask (and have been asked) when both parties sit down together. Answer these questions well and your potential investors are that much more likely to support your company’s vision.

We’ve also included a few “red flags” that you should avoid. Sometimes knowing what gives potential funders pause is just as important as knowing what they are likely to ask.